| # | Drug | Count |
|---|---|---|
| 0 | AMIKACIN SULFATE | 1 |
| 1 | DULAGLUTIDE | 1 |
| 2 | PACLITAXEL | 1 |
| 3 | PACLITAXEL (AIBUMIN-BOUND) | 1 |
| 4 | RAMUCIRUMAB | 1 |
| 5 | TIGECYCLINE | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | AMIKACIN SULFATE | 1 | 0.0006 |
| 1 | TIGECYCLINE | 1 | 0.0002 |
| 2 | RAMUCIRUMAB | 1 | 0.0002 |
| 3 | DULAGLUTIDE | 1 | 0.0000 |
| 4 | PACLITAXEL | 1 | 0.0000 |
| # | Drug class | Count |
|---|---|---|
| 0 | GLP-1 Receptor Agonist [EPC] | 1 |
| 1 | Microtubule Inhibitor [EPC] | 1 |
| 2 | Tetracycline-class Antibacterial [EPC] | 1 |
| 3 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 1 | 0.0002 |
| 1 | Tetracycline-class Antibacterial [EPC] | 1 | 0.0001 |
| 2 | Microtubule Inhibitor [EPC] | 1 | 0.0000 |
| 3 | GLP-1 Receptor Agonist [EPC] | 1 | 0.0000 |